| 8-K | Current report filing | Viking Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 09/28/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Viking Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 09/25/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Viking Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 09/25/2026 | |
| 305B2 | Application for designation of a new tru... | Viking Therapeutics, Inc. | EdgarAgents LLC /fa | 09/24/2026 | |
| FWP | Filing under Securities Act Rules 163/43... | Viking Therapeutics, Inc. | EdgarAgents LLC /fa | 09/24/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Viking Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 09/23/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Viking Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 09/23/2026 | |
| 8-K | Current report filing | Viking Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 09/22/2026 | |
| 3 | Initial statement of beneficial ownershi... | Kelly-gemmell Dorothy Elizabeth | Viking Therapeutics, Inc. | 08/07/2026 | |
| 4 | Statement of changes in beneficial owner... | Kelly-gemmell Dorothy Elizabeth | Viking Therapeutics, Inc. | 08/07/2026 | |
| No record found. |
|
Load More
|